Welcome to our dedicated page for QT IMAGING HOLDINGS SEC filings (Ticker: QTIWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QT IMAGING HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QT IMAGING HOLDINGS's regulatory disclosures and financial reporting.
QT IMAGING HOLDINGS, INC. (QTI) reported that Chief Executive Officer and director Raluca Dinu acquired 484,221 shares of common stock via a grant of Restricted Stock Units. Following this award, she holds 1,393,066 common shares directly.
The RSU vests over time subject to her continued service: three-sixteenths vests on November 15, 2026, and the remaining thirteen-sixteenths in 13 equal quarterly installments on each February 15, May 15, August 15, and November 15, with the award fully vested on February 15, 2030. All shares under this RSU immediately vest upon a Change of Control as defined in the company’s Amended and Restated 2024 Equity Incentive Plan.
QT IMAGING HOLDINGS, INC. (QTI) reported that director Taylor Ross is no longer considered an insider subject to Section 16 reporting as of July 28, 2026. This Form 4 lists no equity transactions, indicating there were no reportable trades or holdings changes by Ross in this filing.
QT Imaging Holdings, Inc. outlined strong mid‑year 2026 progress built around its radiation‑free Breast Acoustic CT imaging platform. In the first half of 2026, the company generated $14.0 million in revenue, up 116% year over year, and shipped 28 scanners. Annual revenue was $4.9 million in 2024 and $18.9 million in 2025, with 2026 revenue guidance of approximately $39 million. More than 12,000 women have been imaged on the platform to date.
QT Imaging completed a $10 million underwritten public offering, extended its senior secured term loan maturity to March 31, 2029, and reported $14.2 million in cash and restricted cash as of August 7, 2026. The company regained listing on the Nasdaq Capital Market and was added to the Russell Microcap Index. Two new FDA clearances expanded system capabilities, and a first routine FDA inspection concluded with zero Form 483 observations. Internationally, QT Imaging obtained regulatory authorizations in Saudi Arabia, the United Arab Emirates, and Israel, and secured a dedicated Category III CPT code for 3D quantitative transmission volumetric breast ultrasound, effective January 1, 2027. The company is relocating to a 22,000‑square‑foot Petaluma facility, more than 2.5x current space with roughly 55% lower lease cost per square foot, to support manufacturing scale and long‑term growth.
QT Imaging Holdings, Inc., a medical device company focused on breast imaging systems, reported strong top-line growth but continued losses for the three and six months ended June 30, 2026. Revenue was $7.4 million for the quarter and $14.0 million year‑to‑date, compared with $3.7 million and $6.5 million in 2025, driven almost entirely by U.S. product sales.
Gross profit rose to $3.1 million for the quarter; however, higher research and development and selling, general and administrative expenses led to a loss from operations of $1.9 million for the quarter and $4.2 million year‑to‑date. Non‑operating items were significant: a $8.3 million loss on debt extinguishment and modification related to the Lynrock Lake term loan and $1.7 million of interest expense contributed to a net loss of $11.1 million for the quarter and $14.5 million for six months.
Cash and cash equivalents were $10.9 million at June 30, 2026, with operating cash outflows of $8.5 million in the first half. Long‑term debt increased to $11.4 million after extending the Lynrock Lake term loan to March 31, 2029 at 12% interest. Stockholders’ equity declined to $2.2 million as liabilities reached $28.4 million against $30.6 million of assets.
QT Imaging uplisted to the Nasdaq Capital Market on January 28, 2026 and raised additional equity through PIPE transactions and a May 2026 underwritten public offering that generated approximately $8.9 million in net proceeds. The company signed distribution agreements with NXC Imaging, Gulf Medical Co., and Al Naghi Medical Co. that include minimum order quantities totaling 195 scanners from 2026 to 2028, representing potential revenue of more than $103 million over that period, supported by recent regulatory approvals in Saudi Arabia and the UAE. Management believes current cash, credit facilities, and expected revenues will fund operations for at least 12 months, while acknowledging ongoing losses and the need for additional capital over time.
QT Imaging Holdings, Inc. reported rapid top-line growth while remaining loss-making for the quarter ended June 30, 2026. Revenue for the second quarter was $7.4 million, up 103% from $3.7 million a year earlier, driven by shipments of fifteen Breast Acoustic CT scanners versus eight in the prior-year quarter. First-half revenue was $14.0 million, up 116% from $6.5 million.
Gross margin was 41%, down from 50% a year ago, reflecting mix and inventory cost dynamics. Total operating expenses rose to $4.9 million from $2.9 million, mainly from higher compensation, professional services, and marketing, resulting in an operating loss of $1.9 million versus a $1.0 million loss last year. A largely non-cash $8.3 million loss on debt extinguishment and modification related to the Lynrock Lake term loan drove total interest and other expense to $9.2 million and pushed net loss to $11.1 million, or $0.75 per share.
Non-GAAP adjusted EBITDA was –$1.2 million. Net cash used in operating activities for the quarter was $4.8 million. QT Imaging strengthened liquidity via an underwritten public offering generating approximately $10.0 million in gross proceeds and extended the maturity of its senior secured term loan from March 2027 to March 2029. Cash and restricted cash totaled $11.0 million as of June 30, 2026 and $14.2 million as of August 7, 2026. The company reaffirmed its 2026 revenue guidance of approximately $39 million and highlighted regulatory wins, expanded manufacturing capacity, and a clean first routine FDA inspection with zero Form 483 observations.
TIMM BRYAN reported acquisition or exercise transactions in this Form 4 filing.
QT Imaging Holdings, Inc. director Bryan Timm reported an award of 9,000 shares of common stock, structured as restricted stock units granted at $0.0000 per share. One-third of the RSU award vests on August 15, 2027, and the remaining two-thirds vest in eight equal quarterly installments through August 15, 2029, subject to his continued service.
QT Imaging Holdings, Inc. reports that director Timm Bryan has filed an initial Form 3 statement of beneficial ownership. The filing lists no insider transactions, no derivative positions, and no reportable holdings in the company’s securities for Bryan at the time of this disclosure.
QT Imaging Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on July 28, 2026. Of the 13,768,903 shares of common stock outstanding and entitled to vote, 8,698,769 shares were represented, constituting a quorum.
Stockholders elected Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the 2029 Annual Meeting. They also ratified BPM LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 and approved an amendment to the 2024 Equity Incentive Plan to increase shares authorized and reserved for issuance.
QT Imaging Holdings is asking stockholders to vote at a virtual annual meeting on July 28, 2026 to elect two Class II directors, ratify BPM LLP as auditor for 2026, and approve an amendment to its 2024 Equity Incentive Plan. The plan amendment would increase shares of common stock reserved for equity awards from 1,827,278 by 550,900 shares (4% of currently issued and outstanding common stock) to 2,378,178. As of the June 23, 2026 record date, 13,768,903 common shares were outstanding. The proxy also highlights 2025 results: revenue rose to $18.9 million, above $18.0 million guidance and up 288% from $4.9 million in 2024, with 40 breast scanners shipped versus 12 in 2024, a 45% gross margin, operating expenses of $13.0 million versus $14.8 million, and a net loss of $21.1 million, or $2.01 per share. Net cash used in operating activities improved to $9.0 million from $10.0 million. The company raised $18.2 million in an October 2025 private placement, completed a 3:1 reverse stock split, uplisted to Nasdaq, and signed exclusive distribution agreements in Saudi Arabia and the UAE.
QT Imaging Holdings is offering $9,999,920 of securities consisting of 1,200,000 shares of common stock and pre-funded warrants to purchase up to 800,000 shares of common stock.
The public offering price is $5.00 per share (pre-funded warrant price equals share price minus $0.0001). Underwriting discounts total $699,994.40, and estimated net proceeds to the company are approximately $9.0 million before expenses. The company reported 12,042,500 shares outstanding as of May 14, 2026, and would have approximately 13,242,500 shares outstanding after the offering assuming none of the pre-funded warrants are exercised.